Tomasz H. Zastawny

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.

Amrita Therapeutics Ltd. develops and commercializes novel drugs for health diseases. The firm engages in dual program of research on both novel peptide-based therapies and development of hybrid therapeutic devices to provide in situ cancer therapy. The company was founded by Ananda M. Chakrabarty and Susan Kling Finston in 2008 and is headquartered in Ahmedabad, India.

Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA.

Part of ICON plc, PRA International LLC is a clinical research organization. The company is based in Raleigh, NC.

ECRC LLC manufactures pharmaceutical products. The private company is based in Edmond. The American company was founded by Tomasz H. Zastawny.